title: Transient infection of freshly isolated human colorectal tumor cells by reovirus T3D intermediate subviral particles.
abstract: Reovirus T3D preferentially kills tumor cells expressing Ras oncogenes and has shown great promise as an anticancer agent in various preclinical tumor models. Here, we investigated whether reovirus can infect and kill tumor cell cultures and tissue fragments isolated from resected human colorectal tumors, and whether this was affected by the presence of endogenous oncogenic KRAS. Tissue fragments and single-cell populations isolated from human colorectal tumor biopsies were infected with reovirus virions or with intermediate subviral particles (ISVPs). Reovirus virions were capable of infecting neither single-cell tumor cell populations nor small fragments of intact viable tumor tissue. However, infection of tumor cells with ISVPs resulted in transient viral protein synthesis, irrespective of the presence of oncogenic KRAS, but this did not lead to the production of infectious virus particles, and tumor cell viability was largely unaffected. ISVPs failed to infect intact tissue fragments. Thermolysin treatment of tumor tissue liberated single cells from the tissue and allowed infection with ISVPs, but this did not result in the production of infectious virus particles. Immunohistochemistry on tissue microarrays showed that junction adhesion molecule 1, the major cellular reovirus receptor, was improperly localized in the cytoplasm of colorectal tumor cells and was expressed at very low levels in liver metastases. This may contribute to the observed resistance of tumor cells to reovirus T3D virions. We conclude that infection of human colorectal tumor cells by reovirus T3D requires processing of virions to ISVPs, but that oncolysis is prevented by a tumor cell response that aborts viral protein synthesis and the generation of infectious viral particles, irrespective of KRAS mutation status.
authors.affiliation: Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
authors.forename: W J
authors.initials: WJ
authors.lastname: van Houdt
authors.forename: N
authors.initials: N
authors.lastname: Smakman
authors.forename: D J M
authors.initials: DJ
authors.lastname: van den Wollenberg
authors.forename: B L
authors.initials: BL
authors.lastname: Emmink
authors.forename: L M
authors.initials: LM
authors.lastname: Veenendaal
authors.forename: P J
authors.initials: PJ
authors.lastname: van Diest
authors.forename: R C
authors.initials: RC
authors.lastname: Hoeben
authors.forename: I H M
authors.initials: IH
authors.lastname: Borel Rinkes
authors.forename: O
authors.initials: O
authors.lastname: Kranenburg
mesh_terms: D001706:Biopsy; D045744:Cell Line, Tumor; D003110:Colonic Neoplasms / Q000235:genetics / Q000473:pathology / Q000601:surgery / Q000821:virology; D015179:Colorectal Neoplasms / Q000235:genetics / Q000473:pathology / Q000601:surgery / Q000821:virology*; D004273:DNA, Neoplasm / Q000235:genetics / Q000302:isolation & purification; D004279:DNA, Viral / Q000235:genetics / Q000302:isolation & purification; D005434:Flow Cytometry; D011905:Genes, ras; D006801:Humans; D012089:Mammalian orthoreovirus 3 / Q000502:physiology; D009362:Neoplasm Metastasis; D012088:Reoviridae Infections / Q000150:complications* / Q000235:genetics; D010948:Viral Plaque Assay; D014779:Virus Replication
chemical_list: D004273:DNA, Neoplasm; D004279:DNA, Viral